Pulmo BioMed Co., Ltd. is a biotechnology pharmaceutical company focusing on new drug development. Pulmo BioMed is committed to the research and development of new protein drugs with precise targets and patented technology.
The aim of our product development is new protein drugs with potential niche markets to improve healthcare quality for patients and subvert the plight of incurable diseases. So far, we have validated the efficacy and safety of a new innovative protein drug “PulmoHeal®” through various experimental verifications, and receive a breakthrough in the treatment of pulmonary fibrosis which is expected to bring new opportunities for patients.
The aim of our product development is new protein drugs with potential niche markets to improve healthcare quality for patients and subvert the plight of incurable diseases. So far, we have validated the efficacy and safety of a new innovative protein drug “PulmoHeal®” through various experimental verifications, and receive a breakthrough in the treatment of pulmonary fibrosis which is expected to bring new opportunities for patients.